Noninvasive near-infrared fluorescent protein-based imaging of tumor progression and metastases in deep organs and intraosseous tissues

Journal of Biomedical Optics

Volumn 19, Issue 1, 2014, Pages

  Jiguet Jiglaire, Carine ^a   Cayol, Mylène ^a   Mathieu, Sylvie ^a   Jeanneau, Charlotte ^a   Bouvier Labit, Corinne ^a   Ouafik, L'Houcine ^a   El Battari, Assou ^a  

^a University of the Mediterranean Aix Marseille II   (France)

Author keywords

Deep tumors; Glioblastoma U87 MG cells; Intraosseous tumors; Melanoma IGR37cells; Metastasis; Near infra red fluorescent protein; Osteosarcoma U2OS cells; Whole body imaging

Indexed keywords

FLUORESCENT PROTEIN; GLIOBLASTOMAS; MELANOMA IGR37CELLS; METASTASIS; OSTEOSARCOMA; WHOLE-BODY IMAGING;

CELLS; CLONING; CYTOLOGY; DERMATOLOGY; FLUORESCENCE; HISTOLOGY; INFRARED DEVICES; MAMMALS; ONCOLOGY; PATHOLOGY; PROTEINS; VIRUSES;

TUMORS;

PHOTOPROTEIN; RED FLUORESCENT PROTEIN;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CHEMISTRY; DISEASE COURSE; GENE VECTOR; GENETICS; GLIOBLASTOMA; HEK293 CELL LINE; HUMAN; IMAGE PROCESSING; LENTIVIRINAE; MALE; MELANOMA; METASTASIS; METHODOLOGY; MOUSE; NEAR INFRARED SPECTROSCOPY; NEOPLASM; NUDE MOUSE; OPTICS; OSTEOSARCOMA; PATHOLOGY; TUMOR CELL LINE; WHOLE BODY IMAGING;

ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; GENETIC VECTORS; GLIOBLASTOMA; HEK293 CELLS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LENTIVIRUS; LUMINESCENT PROTEINS; MALE; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; OPTICS AND PHOTONICS; OSTEOSARCOMA; SPECTROSCOPY, NEAR-INFRARED; WHOLE BODY IMAGING;

EID: 84897806444     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.1.016019     Document Type: Article

References (26)

1. B. Hann and A. Balmain, "Building 'validated' mouse models of human cancer," Curr. Opin. Cell Biol. 13(6), 778-784 (2001). (Pubitemid 33042740)
2. K. Garber, "Realistic rodents? Debate grows over new mouse models of cancer," J. Natl. Cancer Inst. 98(17), 1176-1178 (2006).
3. C. P. Klerk et al., "Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals," Biotechniques 43(S1), 7-13, 30 (2007).
4. M. Bouvet et al., "Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model," Cancer Res. 62(5), 1534-1540 (2002). (Pubitemid 34407819)
5. N. C. Shaner et al., "Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein," Nat. Biotechnol. 22(12), 1567-1572 (2004). (Pubitemid 40039460)
6. R. M. Hoffman, "The multiple uses of fluorescent proteins to visualize cancer in vivo," Nat. Rev. Cancer 5(10), 796-806 (2005). (Pubitemid 41400779)
7. J. Lecoq and M. J. Schnitzer, "An infrared fluorescent protein for deeper imaging," Nat. Biotechnol. 29(8), 715-716 (2011).
8. Y. T. Lim et al., "Selection of quantum dot wavelengths for biomedical assays and imaging," Mol. Imaging 2(1), 50-64 (2003).
9. D. Shcherbo et al., "Bright far-red fluorescent protein for whole-body imaging," Nat. Methods 4(9), 741-746 (2007). (Pubitemid 47338169)
10. X. Shu et al., "Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome," Science 324(5928), 804-807 (2009).
11. G. S. Filonov et al., "Bright and stable near-infrared fluorescent protein for in vivo imaging," Nat. Biotechnol. 29(8), 757-761 (2011).
12. K. Konig, "Multiphoton microscopy in life sciences," J. Microsc. 200(2), 83-104 (2000).
13. C. Mancuso and E. Barone, "The heme oxygenase/biliverdin reductase pathway in drug research and development," Curr. Drug Metab. 10(6), 579-594 (2009).
14. S. Mathieu et al., "Transgene expression of alpha(1, 2)-fucosyltransferase- I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin," Am. J. Pathol. 164(2), 371-383 (2004). (Pubitemid 38364653)
15. Y. Inoue et al., "Diet and abdominal autofluorescence detected by in vivo fluorescence imaging of living mice," Mol. Imaging 7(1), 21-27 (2008).
16. C. Berenguer et al., "Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells," Oncogene 27(4), 506-518 (2008).
17. A. Tchoghandjian et al., "A2B5 cells from human glioblastoma have cancer stem cell properties," Brain Pathol. 20(1), 211-221 (2010).
18. B. C. Gleason and A. F. Nascimento, "HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma," Am. J. Dermatopathol. 29(1), 22-27 (2007). (Pubitemid 46220235)
19. H. Nakayama et al., "Evaluation by bone scintigraphy of osteogenic activity of commercial bioceramics (porous beta-TCP and HAp particles) subcutaneously implanted in rats," J. Biomater. Appl. 24(8), 751-768 (2010).
20. C. Dai and E. C. Holland, "Glioma models," Biochim. Biophys. Acta 1551(1), M19-M27 (2001). (Pubitemid 32831486)
21. R. Taghizadeh et al., "CXCR6, a newly defined biomarker of tissuespecific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells," PLoS One 5(12), e15183 (2010).
22. V. Gray-Schopfer, C. Wellbrock, and R. Marais, "Melanoma biology and new targeted therapy," Nature 445(7130), 851-857 (2007).
23. C. W. Hong and Q. Zeng, "Awaiting a new era of cancer immunotherapy," Cancer Res. 72(15), 3715-3719 (2012).
24. A. Miyawaki, "Fluorescence imaging in the last two decades," J. Electron Microsc. 62(1), 63-68 (2013).
25. R. Weissleder and V. Ntziachristos, "Shedding light onto live molecular targets," Nat. Med. 9(1), 123-128 (2003). (Pubitemid 36098273)
26. W. Qasim, C. A. Vink, and A. J. Thrasher, "Hybrid lentiviral vectors," Mol. Ther. 18(7), 1263-1267 (2010).